Erratum to: Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden

Affiliations

• ¹ Division of Hematology/Oncology, Gunma Cancer Center, 617-1 Takabayashinishicho, Ohta, 373-8550, Japan. [email protected].
• ² Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan.
• ³ Department of Hematology, Tokai Central Hospital, Kakamigahara, Japan.
• ⁴ Department of Hematology, National Cancer Center Hospital East, Chiba, Japan.
• ⁵ Department of Hematology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
• ⁶ Department of Hematology/Oncology, Tokai University School of Medicine, Kanagawa, Japan.
• ⁷ Department of Hematology, Hiroshima University School of Medicine, Hiroshima, Japan.
• ⁸ Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
• ⁹ Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
• ¹⁰ Department of Hematology, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.
• ¹¹ Department of Palliative Care, Saga Prefectural Hospital Koseikan, Saga, Japan.
• ¹² Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
• ¹³ Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
• ¹⁴ Department of Hematology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan.
• ¹⁵ Department of Hematology, National Hospital Organization, Hokkaido Cancer Center, Sapporo, Japan.
• ¹⁶ The University of Tokyo, Tokyo, Japan.
• ¹⁷ Department of Radiology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.
• ¹⁸ Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
• ¹⁹ Department of Nuclear Medicine, Cancer Institute Hospital, Tokyo, Japan.
• ²⁰ Faculty of Science and Engineering, Chuo University, Tokyo, Japan.
• ²¹ Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.